Retatrutide 10 mg multi-dose pen, 3 mL, with green cap and white label

NovaPep

Buy Retatrutide Pen Australia: Retatrutide 10mg Research Pen

$149AUD, GST included

In stock in Australia, batch certificate ready

Size: 10 mg pen, 3 mL

Certificate of analysis published for every batch
Third-party HPLC purity and MS identity testing
Dispatched same day before 3pm cut-off, tracked Australia-wide
Research use only, sold to adults aged 18 and over

Buy Retatrutide Pen Australia stock online from NovaPep, a 10 mg, 3 mL multi-dose research cartridge tested on every lot. The retatrutide pen in Australia is a 3 mL multi-dose pen pre-filled with 10 mg of retatrutide already in solution, so your lab receives a working liquid instead of a dry cake. Inside is LY3437943, a 39 amino acid peptide from Eli Lilly that activates the GIP, GLP-1 and glucagon receptors, at roughly 3.33 mg per mL. The identity data are the same as for the powder, C221H342N46O68, 4731.3 g/mol and CAS 2381089-83-2. Each pen lot goes through mass spectrometry and HPLC, and you can open its report in the COA library before you pay. Pens are dispatched from local stock, and because the contents are already liquid, you will not need bacteriostatic water. Labs that also work from powder can use the retatrutide calculator to set vial concentrations. Adding the tirzepatide pen to the cart gives a dual agonist reference in the very same device. Place the pen in a fridge at 2 to 8 °C as soon as it lands and do not let it freeze. Sold as an in vitro laboratory reagent to customers 18 years or older.

For laboratory research use only. Not for human or veterinary use. Not TGA approved. See the NovaPep research use policy.

What Is the Retatrutide Pen?

Think of the retatrutide pen as a pen-style housing wrapped around a cartridge whose retatrutide has already been dissolved, so your lab receives a working liquid instead of a dry cake. Nothing about the molecule itself is different. For the background on this triple agonist and its origins in Lilly's research pipeline, see the main retatrutide vial page. Here the focus stays on the hardware and on what pre-dissolving a peptide means for your experiment. The Retatrutide Pen is for sale in Australia as a 10 mg, 3 mL research cartridge, ready to order online from local stock.

Eli Lilly, the company that also created tirzepatide, developed retatrutide, and its structure appeared in the literature in the early 2020s. A single molecule switches on receptors for three hormones from the gut and pancreas, namely GIP, GLP-1 and glucagon. This pen supplies that identical compound already dissolved, so the chemistry is unchanged and only the handling differs.

How the Pen and Its Cartridge Work

A cartridge like this is a small glass tube. One end is sealed by a rubber plunger, the other by a rubber septum held beneath a crimped metal cap that a needle can pierce. Each time the pen is advanced, a threaded drive in the barrel pushes the plunger a fixed distance. That repeatable push is why the device counts as multi-dose, since a single cartridge can be drawn on many times until it runs dry. A single-use autoinjector, by contrast, fires everything at once and cannot be reset, while a loose refill cartridge arrives without any pen body. They look alike, yet they are three separate products.

How a Peptide in Solution Differs From a Lyophilised Cake

Water is the enemy of long-term peptide stability, which is exactly why lyophilisation strips it out. When a long chain is dissolved, slow chemistry can begin. Asparagine and glutamine side chains may deamidate, susceptible residues may oxidise and peptide bonds can hydrolyse little by little. Chains may also cling together as aggregates, most often at the air and liquid boundary. Refrigeration slows these processes but never halts them. Freezing is not the answer either, because growing ice concentrates whatever remains dissolved and can strain the seals. Shaking hard introduces more air contact and promotes clumping, so let the pen rest undisturbed in its carton between draws.

Inside the Retatrutide Molecule

Inside the cartridge is a 39 residue peptide on a GIP-like backbone. Non-natural residues guard the positions DPP-4 would otherwise cut, and the C-terminus is amidated. A C20 diacid attached through lysine binds reversibly to albumin, explaining a reported half-life of around six days. In vitro, it is more potent than native GIP at the GIP receptor and less potent than the natural hormones at the GLP-1 and glucagon receptors.

Retatrutide Pen in Laboratory Research

The pen fits work where the triple receptor profile is under study and bench time for preparation is the limiting factor. The research question remains focused on what happens once all three pathways are activated together. This is a research reagent, unrelated to any medicine, and you will find it listed with similar compounds in our metabolic peptides collection. A ready solution also helps groups running one protocol across several benches who need an identical starting concentration at each station. Shop the Retatrutide Pen online in Australia for this research, knowing each lot has been checked for identity and purity.

A frequent mistake is to think of the reta pen as a separate compound with its own biology. It is purely a handling option. Our advice is to pick the pen for studies that draw from one cartridge on a set timetable over a short period, and to stay with powder for open-ended projects or work that might pause. Assay designers should keep one more detail in mind. A pre-filled cartridge contains a vehicle alongside the peptide, so check its composition beforehand and include a vehicle-only control next to your treated wells. Whatever buffer salt or preservative is present will end up in every aliquot drawn.

Retatrutide Pen Specifications

Product	Retatrutide Pen (retatrutide, LY3437943)
Size	10 mg pen in 3 mL
Structure or sequence	GIP-based triple agonist acting at GIP, GLP-1 and glucagon receptors, with a C20 fatty diacid on a lysine side chain
Chain length	39 amino acids
Formula	C221H342N46O68
Molar mass	4731.3 g/mol
CAS	2381089-83-2
Format	Solution in a pre-filled multi-dose cartridge, pen with green cap and viewing window
Analysis	Mass spectrometry for identity, HPLC for purity, certificate per pen lot
In the box	One pen holding 10 mg of retatrutide in 3 mL, about 3.33 mg per mL, with no diluent needed
Storage	Refrigerate at 2 to 8 °C from arrival, protect from light, never freeze
Stock	In stock
Intended use	Laboratory in vitro research only

This green-capped, pre-filled multi-dose pen has a viewing window and contains 10 mg of retatrutide dissolved in 3 mL of liquid. With no powder to look at, the window shows only clear solution, and that is the purpose of the format, because the weighing and dissolving happened before the lot went for testing. The peptide matches the one sold in our lyophilised line, a triple agonist designed by Lilly that the developer has not released commercially in any form so far.

The pen makes most sense when a protocol runs the same steps again and again at a single set concentration and you would rather skip the diluent stage altogether. Every unit leaves our Australian warehouse with a certificate tied to its lot, and a side by side look at pen versus powder vial appears lower on this page.

Verifying a Liquid Peptide

Unlike a powder cake, a liquid offers nothing to inspect by eye, so documentation matters even more. Every pen lot should report a measured mass in line with 4731.3 g/mol along with an HPLC purity figure. Enter the code from the pen label in the COA library to view the report.

Handling and Storage of the Retatrutide Pen

Reconstitution is not part of the process. At roughly 3.33 mg per mL, mixing 0.3 mL from the pen with 0.7 mL of assay buffer gives a 1 mg/mL working solution for in vitro use. When you also work with vials, the retatrutide calculator turns a diluent volume into a concentration. The Retatrutide Pen for sale in Australia leaves our shelves by tracked post, so it reaches your bench in good condition.

Storage is the biggest difference between pen and powder. Retatrutide in solution must never freeze, so hold the pen at 2 to 8 °C inside its carton and out of light, and throw away any pen that has been frozen. Stick to the in-use period shown on the label. Our peptide storage guide explains why liquids and powders need different care.

Retatrutide Pen Compared With Powder Vials and the Tirzepatide Pen

Vials contain lyophilised powder in 10, 20 or 30 mg fills, and the price per milligram drops as the fill grows. Powder lasts longest in the freezer and lets you pick any concentration. The pen gives up that freedom in exchange for a fixed 3.33 mg per mL solution and no preparation at all. Go with powder for exploratory or large-volume studies and with the pen for repeat runs at a single strength. Lots for both formats are tested in the same way.

For a receptor comparison using matching hardware, the tirzepatide pen is the natural partner. It contains the GIP and GLP-1 dual agonist and keeps handling the same while taking the glucagon component out of the picture.

Other Names for the Retatrutide Pen

You may see the active compound called retatrutide, LY3437943, which is its development code, or just reta. The device itself is described as a reta pen, a pre-filled retatrutide cartridge or a multi-dose retatrutide pen. All of these refer to the same 39 residue chain with CAS 2381089-83-2.

On the receptor side, GLP-1R stands for the glucagon-like peptide-1 receptor, GIPR for the glucose-dependent insulinotropic polypeptide receptor and GCGR for the glucagon receptor. Acting on all three is what makes retatrutide a GIP, GLP-1 and glucagon receptor triple agonist.

Retatrutide Status and Safety Alerts in Australia

Health authorities in Australia have kept a close eye on goods sold as retatrutide. A health alert from the Victorian Department of Health on 19 June 2026 reported six cases of acute liver injury among people who had taken unapproved products labelled Retatrutide, Reta, R-10 or R-20. A contaminant was suspected and inquiries were still under way. That alert also called retatrutide an experimental drug that is not approved for sale as a medical product in Australia, consistent with it not appearing on the ARTG as of October 2026.

Why Lot Testing Matters for a Liquid Peptide

For laboratory buyers, the lesson from that alert is simple. A label on a liquid proves nothing by itself. A reta pen you can rely on carries a lot number linked to a mass spectrometry reading close to 4731 g/mol, which distinguishes retatrutide from similar incretin peptides, together with an HPLC purity result. Our guide to reading a certificate of analysis walks through each item to check. NovaPep keeps the 10 mg pen in Australian stock for in vitro research, supplies it only to adults 18 and over, and never provides it for human or veterinary use. For the broader legal context, read whether retatrutide is available in Australia.

Buy the Retatrutide Pen Online in Australia

There is a single format, 10 mg in 3 mL. Our 10 mg retatrutide vial costs less than the pen for the same 10 mg. What the extra buys is a set concentration with no weighing, no mixing and no diluent maths. If your project will grow to 20 or 30 mg, powder is the better fit and also has a longer shelf life.

Pens bought in the same order come from one lot under one certificate, keeping a series of repeat assays on matching material. We only accept orders from customers 18 years or older who confirm the product is for research use.

We have no storefront and no collection point. Laboratories across the country order through this page and are supplied from one domestic stock, and if payment clears before 3pm on a business day the parcel goes out that same day. Buyers looking for peptides on the Gold Coast order here too. Have someone ready to put the parcel in a fridge quickly, and see the delivery information page for transit times.

Retatrutide Pen at a Glance

Pre-Dissolved Retatrutide

Inside the pen is retatrutide, a GIP, GLP-1 and glucagon receptor triple agonist, already in liquid form and ready to draw. You skip the powder and the reconstitution entirely.

Buy the 3 mL, 10 mg Pen online

Each pre-filled multi-dose pen ships from stock in Australia. The fill sets the strength at roughly 3.33 mg per mL, and no diluent is required.

Lab Research on Three Receptors

Suited to in vitro studies of how the incretin and glucagon pathways work together. Sold for laboratory research use only.

Choosing Pen or Powder

Powder vials last longer in the freezer and allow any concentration. The pen skips mixing and delivers the same known concentration each time.

Keep Cold, Do Not Freeze

Put the pen at 2 to 8 °C once it arrives and leave it in its carton away from light. Throw out any pen that has frozen.

Every Lot Tested

Each pen lot is run through mass spectrometry and HPLC, and the matching certificate can be found in the COA library using the label code.

Retatrutide Pen FAQ

What is inside the retatrutide pen?

The pen holds a glass cartridge with 10 mg of retatrutide dissolved in 3 mL, roughly 3.33 mg per mL. Retatrutide is a 39 residue triple agonist of the GIP, GLP-1 and glucagon receptors. The cartridge also contains a vehicle, so a vehicle-only control belongs beside treated wells.

Can I buy retatrutide pens near me from a local shop?

NovaPep is an online-only supplier, so there is no store to walk into. Put the 10 mg, 3 mL pen in your cart, and when payment clears before 3pm on a business day it ships that afternoon to any Australian state or territory. As the peptide is already in solution, make room in a fridge at 2 to 8 °C before it arrives.

Is a certificate of analysis supplied with the Retatrutide Pen?

Yes. Every pen lot is checked by mass spectrometry for the expected retatrutide mass of roughly 4731.3 g/mol and by HPLC for purity. The report shows the same lot code printed on the pen label, and you can view it in the COA library either before or after you buy.

Are other strengths of the retatrutide pen for sale?

No, only one format is offered, 10 mg in 3 mL. If you need more material, the retatrutide vial comes as 10 mg, 20 mg or 30 mg of powder. Powder costs less per milligram, lasts longer in a freezer and allows the lab to choose its own concentration.

Should the retatrutide pen be kept in the fridge?

Yes. Because the peptide is dissolved, the pen needs to sit at 2 to 8 °C from the moment it is delivered, inside its carton and shielded from light. Do not freeze it, and dispose of any pen that has frozen. Follow the in-use period and expiry date printed on the label.

How is the Retatrutide Pen used in laboratory research?

It supplies retatrutide as a ready solution for in vitro studies of GIP, GLP-1 and glucagon receptor signalling, and it suits protocols that repeat a single concentration. It is not a medicine and has no TGA approval. NovaPep sells it strictly for lab work to buyers aged 18 and over.